Germany Power Market Outlook to 2030, Update 2016: Market Trends, Regulations, and Competitive Landscape



Wise.Guy.

Germany Power Market Outlook to 2030, Update 2016 Market Trends, Regulations, and Competitive Landscape

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — This report elaborates Germany's power market structure and provides historical and forecast numbers for capacity, generation, and consumption up to 2030. Detailed analysis of the Germany power market’s regulatory structure, import and export trends, competitive landscape, and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Germany on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario, and future potential. Financial performance of the leading power companies is also analyzed in the report.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729541-germany-power-market-outlook-and-competitive-landscape

Scope
– Snapshot of the country’s power sector across parameters – macro economics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential of the power sector.
– Statistics for installed capacity, power generation and consumption from 2000 to 2015, forecast for the next 15 years to 2030.
– Break-up by technology, including thermal, hydro, renewable and nuclear
– Data on leading current and upcoming projects.
– Information on grid interconnectivity, transmission and distribution infrastructure and power exports and imports.
– Policy and regulatory framework governing the market.
– Detailed analysis of top market participant, including market share analysis and SWOT analysis.

Reasons to buy
– Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the country’s power sector
– Identification of key factors driving investment opportunities in the country’s power sector
– Facilitate decision-making based on strong historic and forecast data
– Develop strategies based on the latest regulatory events
– Position yourself to gain the maximum advantage of the industry’s growth potential
– Identify key partners and business development avenues
– Identify key strengths and weaknesses of important market participants
– Respond to your competitors’ business structure, strategy and prospects.

Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 GlobalData Report Guidance 11
3 Germany, Power Market, Snapshot 12
3.1 Germany, Power Market, Macroeconomic Factors 12
3.2 Germany, Power Market, Supply Security 14
3.3 Germany, Power Market, Opportunities 15
3.4 Germany, Power Market, Challenges 15
4 Germany, Power Market, Market Analysis 17
4.1 Germany, Power Market, Supply Structure 17
4.2 Germany, Power Market, Key Market Players 17
4.3 Germany, Power Market, Financial Deals 18
4.3.1 Deal Volume and Value Analysis, 2004-August 2016 18
4.3.2 Deals by Type, 2015 20
4.4 Germany, Power Market, Demand Structure 21
4.4.1 Germany, Consumption by Sector, 2015 23
5 Germany, Power Market, Regulatory Scenario 24
5.1 Germany, Power Market, Key Electricity Policies 24
5.1.1 Amendment of German Act against Restraints on Competition 25
5.1.2 Amendment of German Energy Act 26
5.1.3 Large Combustion Plant Directive 26
5.1.4 Amendment of German Greenhouse Gas Emission Trading Law 27
5.1.5 Target Grid 2050 27
5.1.6 Renewable Energy Policies 28
5.1.7 Subsidy for Solar Photovoltaic with Storage Installations 29
5.1.8 Nuclear Energy Policies 29
5.1.9 Initiatives to Reduce Greenhouse and Carbon Dioxide Emissions 30
6 Germany, Power Market, Capacity and Generation Overview 31
6.1 Germany, Power Market, Cumulative Installed Capacity, by Fuel Type, 2015 31
6.2 Germany, Power Market, Cumulative Installed Capacity and Annual Power Generation, 2000-2030 32
6.2.1 Cumulative Installed Thermal Capacity and Annual Thermal Power Generation, 2000-2030 35
6.2.2 Cumulative Installed Hydropower Capacity and Annual Hydropower Generation, 2000-2030 39
6.2.3 Cumulative Installed Nuclear Capacity and Annual Nuclear Power Generation, 2000-2030 43
6.2.4 Cumulative Installed Non-hydro Renewable Capacity and Annual Non-hydro Renewable Power Generation, 2000-2030 46
7 Germany, Power Market, Transmission and Distribution Overview 50
7.1 Germany, Power Market, Transmission Overview 50
7.2 Germany, Power Market, Distribution Overview 51
7.3 Germany, Power Market, Grid Interconnection 52
7.3.1 Electricity Import and Export Trends, 2000-2015 54
7.4 Germany, Power Market, Electricity Trading 55
8 Germany, Power Market, Competitive Landscape: Snapshot of Leading Power Generation Companies 56
8.1 Key Company in the Germany Power Market – RWE AG 56
8.1.1 Business Description 56
8.1.2 SWOT Overview 57
8.2 Key Company in the Germany Power Market – E.ON SE 60
8.2.1 Company Overview 60
8.2.2 Business Description 60
8.2.3 SWOT Overview 61
8.3 Key Company in the Germany Power Market – Vattenfall AB 64
8.3.1 Company Overview 64
8.3.2 Business Description 64
8.3.3 SWOT Overview 65
8.4 Key Company in the Germany Power Market – EnBW 68
8.4.1 Company Overview 68
8.4.2 Business Description 68
8.4.3 SWOT Overview 70

Access Report @ https://www.wiseguyreports.com/reports/729541-germany-power-market-outlook-and-competitive-landscape

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Vagus Nerve Stimulators: Medical Devices Pipeline Assessment 2016



Wise.Guy.

Vagus Nerve Stimulators Medical Devices Pipeline Assessment, 2016

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vagus Nerve Stimulators pipeline products.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729489-vagus-nerve-stimulators-medical-devices-pipeline-assessment-2016

This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.

Scope
– Extensive coverage of the Vagus Nerve Stimulators under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Vagus Nerve Stimulators and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Vagus Nerve Stimulators under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Vagus Nerve Stimulators Overview 7
3 Products under Development 8
3.1 Vagus Nerve Stimulators – Pipeline Products by Stage of Development 8
3.2 Vagus Nerve Stimulators – Pipeline Products by Territory 9
3.3 Vagus Nerve Stimulators – Pipeline Products by Regulatory Path 10
3.4 Vagus Nerve Stimulators – Pipeline Products by Estimated Approval Date 11
3.5 Vagus Nerve Stimulators – Ongoing Clinical Trials 12
4 Vagus Nerve Stimulators – Pipeline Products under Development by Companies 13
4.1 Vagus Nerve Stimulators Companies – Pipeline Products by Stage of Development 13
4.2 Vagus Nerve Stimulators – Pipeline Products by Stage of Development 14
5 Vagus Nerve Stimulators Companies and Product Overview 15
5.1 BioControl Medical Company Overview 15
5.1.1 BioControl Medical Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Boston Scientific Corporation Company Overview 17
5.2.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 CerboMed GmbH Company Overview 21
5.3.1 CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Cerebral RX Ltd. Company Overview 22
5.4.1 Cerebral RX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Cyberonics, Inc. Company Overview 23
5.5.1 Cyberonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 DuoCure Ltd. Company Overview 27
5.6.1 DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 ElectroCore, LLC Company Overview 28
5.7.1 ElectroCore, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 LivaNova PLC Company Overview 34
5.8.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 34
5.9 Medical University of South Carolina Company Overview 40
5.9.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 MicroTransponder Inc. Company Overview 42
5.10.1 MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Neurostream Technologies G.P. (Inactive) Company Overview 49
5.11.1 Neurostream Technologies G.P. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Purdue University Company Overview 51
5.12.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 Setpoint Medical Corp Company Overview 52
5.13.1 Setpoint Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 52
5.14 Trifectas Medical Corp. Company Overview 56
5.14.1 Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview 56
6 Vagus Nerve Stimulators- Recent Developments 57
6.1 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 57
6.2 Oct 19, 2016: SetPoint Medical Presents Positive Clinical Results in Crohn’s Disease 58

Access Report @ https://www.wiseguyreports.com/reports/729489-vagus-nerve-stimulators-medical-devices-pipeline-assessment-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Cerebro Spinal Fluid Management : Medical Devices Pipeline Assessment 2016



Wise.Guy.

Cerebro Spinal Fluid Management – Health and Medical Devices Pipeline Assessment, 2016

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cerebro Spinal Fluid Management pipeline products.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729486-cerebro-spinal-fluid-management-medical-devices-pipeline-assessment-2016

This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.

Scope
– Extensive coverage of the Cerebro Spinal Fluid Management under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Cerebro Spinal Fluid Management and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Cerebro Spinal Fluid Management under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 CSF Management Overview 8
3 Products under Development 9
3.1 Cerebro Spinal Fluid Management – Pipeline Products by Stage of Development 9
3.2 Cerebro Spinal Fluid Management – Pipeline Products by Segment 10
3.3 Cerebro Spinal Fluid Management – Pipeline Products by Territory 11
3.4 Cerebro Spinal Fluid Management – Pipeline Products by Regulatory Path 12
3.5 Cerebro Spinal Fluid Management – Pipeline Products by Estimated Approval Date 13
3.6 Cerebro Spinal Fluid Management – Ongoing Clinical Trials 14
4 Cerebro Spinal Fluid Management – Pipeline Products under Development by Companies 15
4.1 Cerebro Spinal Fluid Management Companies – Pipeline Products by Stage of Development 15
4.2 Cerebro Spinal Fluid Management – Pipeline Products by Stage of Development 17
5 Cerebro Spinal Fluid Management Companies and Product Overview 19
5.1 Alcyone Lifesciences, Inc. Company Overview 19
5.1.1 Alcyone Lifesciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Aqueduct Neurosciences Company Overview 22
5.2.1 Aqueduct Neurosciences Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Arkis BioSciences Company Overview 24
5.3.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 Beckersmith Medical, Inc. Company Overview 25
5.4.1 Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Biosan Medical Ltd. Company Overview 26
5.5.1 Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Georgia Institute of Technology Company Overview 28
5.6.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 H-Cubed Inc. Company Overview 30
5.7.1 H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Integra LifeSciences Holdings Corporation Company Overview 31
5.8.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 InVivo Therapeutics Corporation Company Overview 35
5.9.1 InVivo Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
5.10 Kerecis ehf Company Overview 38
5.10.1 Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 38
5.11 Microbot Medical, Ltd. Company Overview 39
5.11.1 Microbot Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 39
5.12 Nanonerve Inc. Company Overview 41
5.12.1 Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.13 NeuraMedica, LLC Company Overview 42
5.13.1 NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 42
5.14 NexGen Medical Systems, Inc. Company Overview 43
5.14.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 44
5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 44
5.16 System Science Inc. Company Overview 46
5.16.1 System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.17 University Hospital Zurich Company Overview 48
5.17.1 University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview 48
5.18 University of Rochester Company Overview 50
5.18.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 University of South Florida Company Overview 51
5.19.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 University of Wisconsin Madison Company Overview 53
5.20.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 53
5.21 Vivonics, Inc. Company Overview 55
5.21.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.22 Wayne State University Company Overview 57
5.22.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 57
6 Cerebro Spinal Fluid Management- Recent Developments 59
6.1 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 59
6.2 Oct 12, 2016: HyperBranch Medical Wins Decision Against Integra Lifesciences 59
6.3 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 60
6.4 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 61
6.5 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 61

Access Report @ https://www.wiseguyreports.com/reports/729486-cerebro-spinal-fluid-management-medical-devices-pipeline-assessment-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Cardiovascular Imaging Equipment Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Cardiovascular Imaging Equipment Treatment Pipeline Review H2 2016

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Imaging Equipment pipeline products.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729485-cardiovascular-imaging-equipment-medical-devices-pipeline-assessment-2016

Scope
– Extensive coverage of the Cardiovascular Imaging Equipment under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Cardiovascular Imaging Equipment and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Cardiovascular Imaging Equipment under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Cardiovascular Imaging Equipment Overview 7
3 Products under Development 8
3.1 Cardiovascular Imaging Equipment – Pipeline Products by Stage of Development 8
3.2 Cardiovascular Imaging Equipment – Pipeline Products by Territory 9
3.3 Cardiovascular Imaging Equipment – Pipeline Products by Regulatory Path 10
3.4 Cardiovascular Imaging Equipment – Pipeline Products by Estimated Approval Date 11
4 Cardiovascular Imaging Equipment – Pipeline Products under Development by Companies 12
4.1 Cardiovascular Imaging Equipment Companies – Pipeline Products by Stage of Development 12
4.2 Cardiovascular Imaging Equipment – Pipeline Products by Stage of Development 13
5 Cardiovascular Imaging Equipment Companies and Product Overview 14
5.1 Arineta Ltd. Company Overview 14
5.1.1 Arineta Ltd. Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Beth Israel Deaconess Medical Center, Inc. Company Overview 15
5.2.1 Beth Israel Deaconess Medical Center, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 CardioPaint Company Overview 16
5.3.1 CardioPaint Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Evena Medical, Inc. Company Overview 17
5.4.1 Evena Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 FMI Technologies, Inc. Company Overview 18
5.5.1 FMI Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 GE Healthcare Limited Company Overview 19
5.6.1 GE Healthcare Limited Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Illumasonix LLC Company Overview 21
5.7.1 Illumasonix LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.8 King's College London Company Overview 22
5.8.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 22
5.9 Medistim ASA Company Overview 23
5.9.1 Medistim ASA Pipeline Products & Ongoing Clinical Trials Overview 23
5.10 Nano4Imaging GmbH Company Overview 26
5.10.1 Nano4Imaging GmbH Pipeline Products & Ongoing Clinical Trials Overview 26
5.11 Perinatronics Medical systems Inc Company Overview 27
5.11.1 Perinatronics Medical systems Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.12 Purdue University Company Overview 28
5.12.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 28
5.13 University of Colorado Company Overview 29
5.13.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 29
5.14 Volcano Corporation Company Overview 30
5.14.1 Volcano Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
5.15 Wisconsin Institute of Nuclear Systems Company Overview 37
5.15.1 Wisconsin Institute of Nuclear Systems Pipeline Products & Ongoing Clinical Trials Overview 37
6 Cardiovascular Imaging Equipment- Recent Developments 39
6.1 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 39
6.2 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 40
6.3 Oct 24, 2016: St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference 41
6.4 Oct 20, 2016: Medistim: Results for the Third Quarter 2016 42
6.5 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 43
6.6 Oct 18, 2016: FluoroPharma Medical Enters into Partnership with Koninklijke Philips 45
6.7 Oct 11, 2016: LiDCO GROUP: Interim Results for the six months ended 31 July 2016 45
6.8 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 49
6.9 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 50
6.10 Sep 08, 2016: Lantheus Holdings Prices Public Offering of Shares For USD40 Million 50
6.11 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 51
6.12 Aug 24, 2016: Medistim: 2nd quarter and 1st half report for 2016 53
6.13 Aug 23, 2016: Philips showcases full suite of cardiology solutions for personalized approach to prevention, diagnosis and treatment of cardiovascular disease at ESC Congress 2016 57
6.14 Aug 10, 2016: Arineta CT FDA Clearance 58
6.15 Aug 09, 2016: Stereotaxis Reports 2016 Second Quarter Financial Results 59

Access Report @ https://www.wiseguyreports.com/reports/729485-cardiovascular-imaging-equipment-medical-devices-pipeline-assessment-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Automotive Valve Tappet Market – Opportunities and Forecast 2016 – 2021

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Automotive Valve Tappet Market

This report studies Automotive Valve Tappet in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Federal-Mogul
Hylift-Johnson
TRW
SM Motorenteile GmbH
ACDelco
Ford Performance
Riken
Johnson Lifter
ARCEK
Ferrea
Rsr Industries
Aarti Forging
Auto7
Deshpande
Decora Auto
Zhenhua
Yangchen
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Automotive Valve Tappet in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Request Sample Report @ https://www.wiseguyreports.com/sample-request/744277-global-automotive-valve-tappet-market-research-report-2016

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Automotive Valve Tappet in each application, can be divided into
Application 1
Application 2
Application 3

Complete Report Details @ https://www.wiseguyreports.com/reports/744277-global-automotive-valve-tappet-market-research-report-2016

Table of Contents

Global Automotive Valve Tappet Market Research Report 2016
1 Automotive Valve Tappet Market Overview
1.1 Product Overview and Scope of Automotive Valve Tappet
1.2 Automotive Valve Tappet Segment by Type
1.2.1 Global Production Market Share of Automotive Valve Tappet by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Automotive Valve Tappet Segment by Application
1.3.1 Automotive Valve Tappet Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Automotive Valve Tappet Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Automotive Valve Tappet (2011-2021)

2 Global Automotive Valve Tappet Market Competition by Manufacturers
2.1 Global Automotive Valve Tappet Production and Share by Manufacturers (2015 and 2016)
2.2 Global Automotive Valve Tappet Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Automotive Valve Tappet Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Automotive Valve Tappet Manufacturing Base Distribution, Sales Area and Product Type
2.5 Automotive Valve Tappet Market Competitive Situation and Trends
2.5.1 Automotive Valve Tappet Market Concentration Rate
2.5.2 Automotive Valve Tappet Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Automotive Valve Tappet Production, Revenue (Value) by Region (2011-2016)
3.1 Global Automotive Valve Tappet Production by Region (2011-2016)
3.2 Global Automotive Valve Tappet Production Market Share by Region (2011-2016)
3.3 Global Automotive Valve Tappet Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Automotive Valve Tappet Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Automotive Valve Tappet Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Automotive Valve Tappet Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Automotive Valve Tappet Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Automotive Valve Tappet Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Automotive Valve Tappet Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Automotive Valve Tappet Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Automotive Valve Tappet Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Automotive Valve Tappet Consumption by Regions (2011-2016)
4.2 North America Automotive Valve Tappet Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Automotive Valve Tappet Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Automotive Valve Tappet Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Automotive Valve Tappet Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Automotive Valve Tappet Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Automotive Valve Tappet Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Automotive Valve Tappet Production, Revenue (Value), Price Trend by Type
5.1 Global Automotive Valve Tappet Production and Market Share by Type (2011-2016)
5.2 Global Automotive Valve Tappet Revenue and Market Share by Type (2011-2016)
5.3 Global Automotive Valve Tappet Price by Type (2011-2016)
5.4 Global Automotive Valve Tappet Production Growth by Type (2011-2016)

..……CONTINUED

For more information or any query mail at sales@wiseguyreports.com

Check Discount on This Report @ https://www.wiseguyreports.com/check-discount/744277-global-automotive-valve-tappet-market-research-report-2016

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Household Cleaning Market to Grow at a 22.74% CAGR Forecast to 2021

Household Cleaning Market 2016 Indian Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast to 2021

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — This report gives an in-depth analysis of household cleaning industry. The household cleaning industry in India is highly unorganized and the size of unorganized sector is three times than that of organized one. However, this report includes only the organized sector i.e. the branded household cleaning market. The organized household cleaning market in India is mainly split into three broad categories viz. utensil cleaner, toilet cleaner and surface cleaner. Utensil cleaners are further split into dishwashing bar, liquid, powder and pastes. Toilet cleaners consist of liquid cleaners, in-cisterns & rim blocks whereas surface cleaners are split into floor cleaner, specialized and multipurpose cleaners. The specialized cleaners are further split, based on their application areas.
Request a sample report @ https://www.wiseguyreports.com/sample-request/744771-india-household-cleaning-market-outlook-2021
According to “India Household Cleaning Market Outlook, 2021”, the overall market for household cleaning is anticipated to grow with a CAGR of 22.74% in the next five years. In utensil cleaning category, dishwashing bars dominate market revenues, followed by liquid cleaners whereas dishwashing paste has negligible contribution. Consumers in urban areas are now upgrading to dishwashing liquids which are expected to register robust growth in the forecast period. Powder based utensil cleaners are now set to diminish from the market. The surface cleaning market is growing mainly because of rising awareness about brands due to heavy promotion by leading companies. Floor cleaners dominate category revenues, followed by specialized and multi-purpose cleaners. Surface cleaners are targeted mainly at urban households and thus are more popular in urban markets.

Liquid toilet cleaners are popular in Indian market because of low unit prices and age old preference of consumers. Toilet in-cisterns and rim blocks are growing very fast due to their enhanced cleaning methods and easy to use advantages. Household cleaning products are largely sold through modern retail stores like supermarkets, hypermarkets and malls. Traditional grocery stores are reluctant to store them on their shelves because of their high price and low probability of selling. Online sales of household cleaning products remain negligible; however expected to grow in future due to rising mobile phone and internet penetration in the country. Major companies in the household cleaning market include Hindustan Unilever, Reckitt Benckiser, Jyothy Laboratories, Rohit Surfactants, Dabur India, SC Johnson etc. Major brands operating in the industry are Vim, Harpic, Pril, Exo, Xpert, Lizol, Domex, Colin, Sani Fresh, Cif, Mr Muscle, Easy Off Bang, Dazzl, Dettol etc.

Key Categories
Utensil Cleaner
Surface Cleaner
Toilet Cleaner
Complete report details @ https://www.wiseguyreports.com/reports/744771-india-household-cleaning-market-outlook-2021
Key points in table of content
1. Executive Summary
2. Global Household Cleaning Market Outlook
2.1. Global Utensil Cleaner Market Outlook
2.2. Global Surface Cleaner Market Outlook
2.3. Global Toilet Cleaner Market Outlook
3. India Household Cleaning Market Outlook
3.1. Market Size By Value
3.2. Market Share
3.2.1. By Company
3.2.2. By Brand
3.2.3. By Category
3.2.4. By Demographics
3.2.5. By Sales Channel
3.3. Product, Price and Variant Analysis
3.3.1. Utensil Cleaning Bar
3.3.2. Utensil Cleaning Liquid
3.3.3. Utensil Cleaning Powder
3.3.4. Utensil Cleaning Paste
3.3.5. Floor Cleaner
3.3.6. Specialized Cleaner
3.3.7. Multi-Purpose Cleaner
3.3.8. Liquid Toilet Cleaners
3.3.9. Toilet Rim Block
3.3.10. In-Cistern Toilet Cleaner
4. India Utensil Cleaner Market Outlook
4.1. Market Size By Value
4.2. Market Share
4.2.1. By Company
4.2.2. By Brand
4.2.3. By Product Type
4.2.4. By Demographics
4.2.5. By Sales Channel
4.3. India Bar Utensil Cleaner Market
4.4. India Liquid Utensil Cleaner Market
4.5. India Powder Utensil Cleaner Market
4.6. India Paste Utensil Cleaner Market
5. India Surface Cleaner Market Outlook
5.1. Market Size By Value
5.2. Market Share
5.2.1. By Company
5.2.2. By Brand
5.2.3. By Segment
5.2.4. By Demographics
5.2.5. By Sales Channel
5.3. India Floor Cleaner Market
5.4. India Specialized Cleaner Market
5.5. India Multi-Purpose Cleaner Market
6. India Toilet Cleaner Market Outlook
6.1. Market Size By Value
6.2. Market Share
6.2.1. By Company
6.2.2. By Product Type
6.2.3. By Demographics
6.2.4. By Sales Channel
7. India Economic Snapshot
8. Raw Material
9. Market Penetration
10. Future Development
11. Policy & Regulatory Landscape
12. Trade Dynamics
12.1. Import
12.2. Export
13. Channel Partner Analysis
14. India Household Cleaning Market Dynamics
14.1. Key Drivers
14.2. Key Challenges
15. Market Trends & Developments
15.1. Increasing Importance of Hygiene for Ensuring Wellbeing
15.2. Competition Between Private Labels and National Brands
15.3. Marketers Leveraging Government's Initiative for Cleanliness
15.4. Multi-Purpose Cleaners Gaining Popularity
15.5. Organic Products & Eco Friendly Formulations
15.6. Growing Sanitation Awareness in India
16. Competitive Landscape
16.1. Porters Five Forces
16.2. Company Profiles
16.2.1. Reckitt Benckiser (India) Ltd.
16.2.2. Hindustan Unilever Limited
16.2.3. Dabur India Limited
16.2.4. SC Johnson Products Pvt. Ltd.
16.2.5. Jyothy Laboratories Limited
16.2.6. Venky's (India) Limited
16.2.7. Future Consumer Enterprise Ltd.
16.2.8. Fena Private Limited
16.2.9. Pitambari Products Pvt. Ltd.
16.2.10. The Clorox Company
17. Strategic Recommendations
18. Disclaimer
Get this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=744771
Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Peripheral Lung Cancer Market Global Industry Analysis 2016

Peripheral Lung Cancer -Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication

PUNE, INDIA , November 16, 2016 /EINPresswire.com/ — Global Peripheral Lung Cancer Market

DelveInsight’s, “Peripheral Lung Cancer -Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the 12 pipeline drugs that fall under the category of Peripheral Lung Cancer. Peripheral lung cancer usually begins in tissues that lie near the outer parts of the lungs, and may be diagnosed later in due course of time.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/476525-peripheral-lung-cancer-pipeline-insights-2016

The report also provides the recent trends as these days’ companies are focusing on the Targeted Therapy for cancer majorly on the inner working of the lung cancer cells and process, which will control their growth and spread. Morphotek’s Farletuzumab is the only monoclonal antibody in Phase II competing against the other small molecules in development along with Solitomab of Amgen in Phase I.
Recent report of Delveinsight covers drugs that are being developed with novel approach to target or intervene along the pathways of tumorigenesis. Currently in pipeline, we can observe close competition between the Phase II drugs of Big Pharma such as Pfizer and Eisai along with mid tier companies such as Hanmi, Axelar and Morphotek. Boehringer is leading both in market as well as in pipeline with Afatinib in Phase III stage of development.

Scope:
• The new report, provides a Peripheral Lung Cancer Landscape across the globe
• The report provides drug profiles which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, Preclinical and Discovery stages
• Coverage of the Peripheral Lung Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Peripheral Lung Cancer and also provide company profiling
• Pipeline products coverage based on various stages of development from NDA filings to discovery.
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type.

Access Complete Report @ https://www.wiseguyreports.com/reports/476525-peripheral-lung-cancer-pipeline-insights-2016

Reasons to Buy:
• Complete Pipeline intelligence and complete understanding over therapeutics development for Peripheral Lung Cancer
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Peripheral Lung Cancer pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table of Content:

Peripheral Lung Cancer Overview
• Types
• Peripheral Lung Cancer (Lung adenocarcinoma)
• Epidemiology
• Diagnosis of adenocarcinoma
• Treatment of Adenocarcinoma of the lung
• Pipeline Therapeutics
• Therapeutics under Development by Companies
• Last Stage Products (Phase III)
• Comparative Analysis
• Mid Stage Products (Phase II)
• Comparative Analysis
• Early Stage Products (Phase I and IND)
• Comparative Analysis
• Discovery and Pre-clinical Stage Products
• Comparative Analysis
• Therapeutic Assessment
• Assessment by Monotherapy Products
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Dormant Products
• Companies involved in Therapeutics Development
• Appendix
• Methodology
• Consulting Services
• About DelveInsight
• Contact Us
• Disclaimer
List of tables:

Table 1: Number of Products Under Development for Peripheral Lung Cancer, 2016
• Table 2: Number of Products under Development by Companies,2016
• Table 3: Last Stage Products (Phase III and Filed),2016
• Table 4: Mid Stage Products (Phase II), 2016
• Table 5: Early Stage Products (Phase I and IND), 2016
• Table 6: Discovery and Pre-clinical Stage Products, 2016
• Table 7: Assessment by Monotherapy Products, 2016
• Table 8: Assessment by Route Of Administration, 2016
• Table 9: Assessment by Stage and Route Of Administration, 2016
• Table 10: Assessment by Molecule Type, 2016
• Table 11: Assessment by Stage and Molecule Type, 2016
• Table 12: Dormant Drugs, 2016
• Table 13: Companies Involved in Therapeutic Development, 2016
List of figures:

Figure 1: Number of Products under Development for Peripheral Lung Cancer, 2016
• Figure 2: Last Stage Products (Phase III) 2016
• Figure 3: Mid Stage Products (Phase II), 2016
• Figure 4:Early Stage Products (Phase I and IND), 2016
• Figure 5: Discovery and Pre-clinical Stage Products, 2016
• Figure 6: Assessment by Monotherapy Products, 2016
• Figure 7: Assessment by Route of Administration, 2016
• Figure 8: Assessment by Stage and Route of Administration, 2016
• Figure 9: Assessment by Molecule Type, 2016
• Figure 10: Assessment by Stage and Molecule Type, 2016
Buy Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=476525

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Global Anticoagulants Market to Grow at a CAGR Of 8.59% to Forecast 2020

Global Anticoagulants Market to Grow at a CAGR Of 4.64% to Forecast 2020

PUNE, INDIA , November 16, 2016 /EINPresswire.com/ — Global Anticoagulants Market

The Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF) -2020 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan.

According to DelveInsight, Global Anticoagulants Market to Grow at a CAGR Of 4.64% to Forecast 2020

Try Sample Report @ https://www.wiseguyreports.com/sample-request/476538-anticoagulants-market-insights-drugs-sales-forecast-vte-af-2020

Coagulation is an important phenomenon of body to stop external bleeding but when clots are formed in blood vessels, it can be lethal. Blood clots in arteries can lead to heart attack and when formed in the blood vessels of brain can lead to stroke. Thus, anticoagulants are used to prevent the formation of blood clots in the body. Anticoagulants are proved to be a beneficial medication for the treatment of Atrial fibrillation, Deep Vein Thrombosis, Pulmonary Embolism and Stroke. Globally the overall incidence for Venous Thromboembolism (VTE) and Atrial fibrillation (AF) is increasing at a higher rate. For VTE, there are approximately 1 million cases in the United States each year, many of which represent recurrent disease and AF affects approximately 3 million patients in the US, and over 6.7 million in the US and Europe combined.

Key Coverage and Benefits:
• The report will help in developing business strategies by understanding the trends shaping and driving the global Venous Thromboembolism (VTE) market.
• Identifying patient populations in the global Venous Thromboembolism (VTE) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Venous Thromboembolism (VTE) therapeutics in each of the markets covered.
• To understand the future market competition in the global Venous Thromboembolism (VTE) therapeutics market and Insightful review of the key market drivers and barriers.

Access Complete Report @ https://www.wiseguyreports.com/reports/476538-anticoagulants-market-insights-drugs-sales-forecast-vte-af-2020

Scope of the Report:

• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2015-2020.
• It also provides Venous Thromboembolism (VTE) for United States, EU5 and Japan from 2015 and forecasted Market to 2020.

Table of Contents
Executive Summary
Market Share of Anticoagulants in 2015 and 2020
Worldwide Market Share of Anticoagulants in 2015
Worldwide Market Share of Anticoagulants in 2020
Chapter 1 Anticoagulants Introduction
Warfarin
Low Molecular Weight Heparins
New Oral Anticoagulants (NOAC)
Chapter 2 Venous Thromboembolism
Disease Overview
Epidemiology of Venous Thromboembolism
Treatment Landscape
Treatment Algorithm
Treatment Goals
Treatment Details
Chapter 3 Atrial Fibrillation
Disease Overview
Epidemiology of Atrial Fibrillation
Treatment Landscape
Treatment Algorithm
Treatment Goals
Treatment Details
Chapter 4 Key Marketed Anticoagulants
Novel Oral Anticoagulants Comparison
Reversal Agents (Antidotes)
Chapter 5 Anticoagulants Market Assessment
Key Findings
Global Anticoagulants Sales
Global Anticoagulants Market by Drugs
Global Anticoagulants Market Share (%)
Global Anticoagulants Market Sales by Atrial Fibrillation (AF)
Global Anticoagulants Market Share (%) in Atrial Fibrillation
Global Anticoagulants Market Sales by Venous Thromboembolism
Global Anticoagulants Market Share (%) in Venous Thromboembolism
Chapter 6 United States Anticoagulants Market Assessment
Key Findings
United States Anticoagulants Market
United States Anticoagulants Market Share (%)
United States Anticoagulants Market Sales by Atrial Fibrillation
United States Anticoagulants Market Share (%) in Atrial Fibrillation
United States Anticoagulants Market Sales by Venous Thromboembolism
United States Anticoagulants Market Share (%) in Venous
Thromboembolism
Chapter 8 Europe 5 Anticoagulants Market Assessment
Key Findings
Europe 5 Anticoagulants Market
Europe 5 Anticoagulants Market Share (%)
Europe 5 Anticoagulants Market Sales by Atrial Fibrillation
Europe 5 Anticoagulants Market Share (%) in Atrial Fibrillation
Europe 5 Anticoagulants Market Sales by Venous Thromboembolism
Europe 5 Anticoagulants Market Share (%) in Venous Thromboembolism
Chapter 10 Japan Anticoagulants Market Assessment
Key Findings
Japan Anticoagulants Market
Japan Anticoagulants Market Share (%)
Japan Anticoagulants Market Sales by Atrial Fibrillation
Japan Anticoagulants Market Share (%) in Atrial Fibrillation
Japan Anticoagulants Market Sales by Venous Thromboembolism
Japan Anticoagulants Market Share (%) in Venous Thromboembolism
Chapter 12 Xarelto (rivaroxaban) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy of Xarelto
Safety of Xarelto
Side effects of Drugs
Cost of Therapy
Global Drug Sales
Xarelto Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Xarelto Historical Sales and Forecasted Sales (2011-2020) by AF
Xarelto Historical Sales and Forecasted Sales (2011-2020) by VTE
Clinical Trials Information
SWOT Analysis of Xarelto
Chapter 13 Pradaxa (dabigatran etexilate mesylate) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy of Pradaxa
Safety of Pradaxa
Side effects of Drugs
Cost of Therapy
Global Drug Sales
Pradaxa Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Pradaxa Historical Sales and Forecasted Sales (2011-2020) by AF
Pradaxa Historical Sales and Forecasted Sales (2011-2020) by VTE
Clinical Trial Information
SWOT Analysis of Pradaxa
Chapter 15 Eliquis(Apixaban) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy and Safety of Eliquis
Side effects of Eliquis
Cost of Therapy
Global Drug Sales
Eliquis Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Eliquis Historical Sales and Forecasted Sales (2011-2020) by AF
Eliquis Historical Sales and Forecasted Sales (2011-2020) by VTE
Clinical Trial Information
SWOT Analysis of Eliquis
Chapter 16 Savaysa (edoxaban tosylate) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy of Savaysa
Safety of Savaysa
Side Effects of Savaysa
Cost of Therapy
Global Drug Sales
Savaysa Historical Sales and Forecasted Sales (2011-2020)

Continued….

Buy Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=476538

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Global Atrial Fibrillation (AF) Market to Grow at a CAGR Of 11.62% to Forecast 2020

Global Atrial Fibrillation market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate of 11.62%.

PUNE, INDIA , November 16, 2016 /EINPresswire.com/ — Global Atrial Fibrillation Market

The Atrial Fibrillation-Market Insights & Drugs Sales Forecast (AF) -2020 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. According to DelveInsight, Global Atrial Fibrillation market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/476536-atrial-fibrillation-market-insights-drugs-sales-forecast-af-2020

Coagulation is an important phenomenon of body to stop external bleeding but when clots are formed in blood vessels, it can be lethal. Blood clots in arteries can lead to heart attack and when formed in the blood vessels of brain can lead to stroke. Thus, anticoagulants are used to prevent the formation of blood clots in the body. Anticoagulants are proved to be a beneficial medication for the treatment of Atrial fibrillation, Deep Vein Thrombosis, Pulmonary Embolism and Stroke.

Key Coverage and Benefits:

The report will help in developing business strategies by understanding the trends shaping and driving the global Atrial Fibrillation (AF) market.
• Identifying patient populations in the global Atrial Fibrillation (AF) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Atrial Fibrillation (AF) therapeutics in each of the markets covered.
• To understand the future market competition in the global Atrial Fibrillation (AF) therapeutics market and Insightful review of the key market drivers and barriers.
Access Complete Report @ https://www.wiseguyreports.com/reports/476536-atrial-fibrillation-market-insights-drugs-sales-forecast-af-2020

Scope of the Report:

• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2015-2020.
• It also provides Atrial fibrillation (AF) for United States, EU5 and Japan from 2015 and forecasted Market to 2020.

Executive Summary
Market Share of Anticoagulants in 2015 and 2020
Worldwide Market Share of Anticoagulants in 2015
Worldwide Market Share of Anticoagulants in 2020
Chapter 1 Anticoagulants Introduction
Warfarin
Low Molecular Weight Heparins
New Oral Anticoagulants (NOAC)
Chapter 2 Atrial Fibrillation
Disease Overview
Epidemiology of Atrial Fibrillation
Treatment Landscape
Treatment Algorithm
Treatment Goals
Treatment Details
Chapter 3 Key Marketed Anticoagulants
Novel Oral Anticoagulants Comparison
Reversal Agents (Antidotes)
Chapter 4 Anticoagulants Market Assessment by AF
Key Findings
Global Anticoagulants Market Sales by Atrial Fibrillation (AF)
Global Anticoagulants Market Share (%) in Atrial Fibrillation
Chapter 5 United States Anticoagulants Market Assessment by AF
Key Findings
United States Anticoagulants Market Sales by Atrial Fibrillation
United States Anticoagulants Market Share (%) in Atrial Fibrillation
Chapter 6 Europe 5 Anticoagulants Market Assessment by AF
Key Findings
Europe 5 Anticoagulants Market Sales by Atrial Fibrillation
Europe 5 Anticoagulants Market Share (%) in Atrial Fibrillation
Chapter 7 Japan Anticoagulants Market Assessment by AF
Key Findings
Japan Anticoagulants Market Sales by Atrial Fibrillation
Japan Anticoagulants Market Share (%) in Atrial Fibrillation
Chapter 8 Xarelto (rivaroxaban) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy of Xarelto
Safety of Xarelto
Side effects of Drugs
Cost of Therapy
Global Drug Sales
Xarelto Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Xarelto Historical Sales and Forecasted Sales (2011-2020) by AF
Clinical Trials Information
SWOT Analysis of Xarelto
Chapter 9 Pradaxa (dabigatran etexilate mesylate) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy of Pradaxa
Safety of Pradaxa
Side effects of Drugs
Cost of Therapy
Global Drug Sales
Pradaxa Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Pradaxa Historical Sales and Forecasted Sales (2011-2020) by AF
Clinical Trial Information
SWOT Analysis of Pradaxa
Chapter 10 Eliquis(Apixaban) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy and Safety of Eliquis
Side effects of Eliquis
Cost of Therapy
Global Drug Sales
Eliquis Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Eliquis Historical Sales and Forecasted Sales (2011-2020) by AF
Clinical Trial Information
SWOT Analysis of Eliquis
Chapter 11 Savaysa (edoxaban tosylate) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy of Savaysa
Safety of Savaysa
Side Effects of Savaysa
Cost of Therapy
Global Drug Sales
Savaysa Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Savaysa Historical Sales and Forecasted Sales (2011-2020) by AF
Clinical Trial Information
SWOT Analysis of Savaysa
Chapter 12 Market Drivers and Constraints
Factors Driving the Market Growth
Factors Constraining the Market Growth
Consulting Services
Disclaimer
About DelveInsight

Purchase Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=476536

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Global Automotive Smart Key Market 2016 Share, Trend, Segmentation and Forecast to 2021

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Automotive Smart Key

Notes:

Production, means the output of Automotive Smart Key

Revenue, means the sales value of Automotive Smart Key

This report studies Automotive Smart Key in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/590885-global-automotive-smart-key-market-professional-survey-report-2016

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Continental
Denso
TRW
Omron
Delphi
Tokai Rika
HELLA
Calsonic Kansei
Kostal
Valeo
Lear
Mitsubishi

Alps Electric

Would like to place an order @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=590885

By types, the market can be split into

Remote Keyless Entry Systems
Passive Keyless Entry Systems
Type III

By Application, the market can be split into

Application 1
Application 2
Application 3

By Regions, this report covers (we can add the regions/countries as you want)

North America
China
Europe
Southeast Asia
Japan
India

Table of Contents

Global Automotive Smart Key Market Professional Survey Report 2016

1 Industry Overview of Automotive Smart Key

1.1 Definition and Specifications of Automotive Smart Key

1.1.1 Definition of Automotive Smart Key

1.1.2 Specifications of Automotive Smart Key

1.2 Classification of Automotive Smart Key

1.2.1 Remote Keyless Entry Systems

1.2.2 Passive Keyless Entry Systems

1.2.3 Type III

1.3 Applications of Automotive Smart Key

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

2 Manufacturing Cost Structure Analysis of Automotive Smart Key

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Automotive Smart Key

2.3 Manufacturing Process Analysis of Automotive Smart Key

2.4 Industry Chain Structure of Automotive Smart Key

3 Technical Data and Manufacturing Plants Analysis of Automotive Smart Key

3.1 Capacity and Commercial Production Date of Global Automotive Smart Key Major Manufacturers in 2015

3.2 Manufacturing Plants Distribution of Global Automotive Smart Key Major Manufacturers in 2015

3.3 R&D Status and Technology Source of Global Automotive Smart Key Major Manufacturers in 2015

3.4 Raw Materials Sources Analysis of Global Automotive Smart Key Major Manufacturers in 2015

4 Global Automotive Smart Key Overall Market Overview

4.1 2011-2016E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2011-2016E Global Automotive Smart Key Capacity and Growth Rate Analysis

4.2.2 2015 Automotive Smart Key Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2011-2016E Global Automotive Smart Key Sales and Growth Rate Analysis

4.3.2 2015 Automotive Smart Key Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2011-2016E Global Automotive Smart Key Sales Price

4.4.2 2015 Automotive Smart Key Sales Price Analysis (Company Segment)

5 Automotive Smart Key Regional Market Analysis

5.1 North America Automotive Smart Key Market Analysis

5.1.1 North America Automotive Smart Key Market Overview

5.1.2 North America 2011-2016E Automotive Smart Key Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2011-2016E Automotive Smart Key Sales Price Analysis

5.1.4 North America 2015 Automotive Smart Key Market Share Analysis

5.2 China Automotive Smart Key Market Analysis

5.2.1 China Automotive Smart Key Market Overview

5.2.2 China 2011-2016E Automotive Smart Key Local Supply, Import, Export, Local Consumption Analysis

5.2.3 China 2011-2016E Automotive Smart Key Sales Price Analysis

5.2.4 China 2015 Automotive Smart Key Market Share Analysis

5.3 Europe Automotive Smart Key Market Analysis

5.3.1 Europe Automotive Smart Key Market Overview

5.3.2 Europe 2011-2016E Automotive Smart Key Local Supply, Import, Export, Local Consumption Analysis

5.3.3 Europe 2011-2016E Automotive Smart Key Sales Price Analysis

5.3.4 Europe 2015 Automotive Smart Key Market Share Analysis

5.4 Southeast Asia Automotive Smart Key Market Analysis

5.4.1 Southeast Asia Automotive Smart Key Market Overview

5.4.2 Southeast Asia 2011-2016E Automotive Smart Key Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Southeast Asia 2011-2016E Automotive Smart Key Sales Price Analysis

5.4.4 Southeast Asia 2015 Automotive Smart Key Market Share Analysis

5.5 Japan Automotive Smart Key Market Analysis

5.5.1 Japan Automotive Smart Key Market Overview

5.5.2 Japan 2011-2016E Automotive Smart Key Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Japan 2011-2016E Automotive Smart Key Sales Price Analysis

5.5.4 Japan 2015 Automotive Smart Key Market Share Analysis

5.6 India Automotive Smart Key Market Analysis

5.6.1 India Automotive Smart Key Market Overview

5.6.2 India 2011-2016E Automotive Smart Key Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2011-2016E Automotive Smart Key Sales Price Analysis

5.6.4 India 2015 Automotive Smart Key Market Share Analysis

……Continued

Access Complete Report@ https://www.wiseguyreports.com/reports/590885-global-automotive-smart-key-market-professional-survey-report-2016

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: EINPresswire.com